Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia

Cancer

Volumn 115, Issue 5, 2009, Pages 1100-1108

  Sung, Lillian ^a   Garnis, Alan ^b   Alonzo, Todd A ^c,d   Buxton, Allen ^d   Britton, Kristen ^e   DeSwarte Wallace, Joetta ^f   Woods, William G ^g  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

^e SINAI HOSPITAL OF BALTIMORE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

Acute myeloid leukemia; Children; Infections; Stem cell transplantation

Indexed keywords

ASPARAGINASE; AZACITIDINE; BUSULFAN; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; NYSTATIN; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BLOOD CELL COUNT; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CAUSE OF DEATH; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION COMPLICATION; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; INTENSIVE CARE; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE CYCLE TREATMENT; MYCOSIS; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; VIRUS INFECTION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; HUMANS; INFECTION; LEUKEMIA, MYELOID, ACUTE; MYCOSES; STEM CELL TRANSPLANTATION; VIRUS DISEASES;

EID: 61449133218     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24107     Document Type: Article

References (14)

1. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AMUUBFM 98. J Clin Oncol. 2004;22:4384-4393.
2. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid, leukemia: analysis of the prospective multi-institutional clinical, trial AML-BFM 93. Leukemia. 2004;18:72-77.
3. Riley LC, Hann IM, Wheatley K, Stevens RF. Treatment-related, deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AMLlO). The MCR Childhood Leukaemia Working Party. Br J Haematol. 1999;106:436-444.
4. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110:3532-3539.
5. Lange BJ, Smith FO, Feusner J, et al. Outcomes in CCG-2961, a Children's Cancer Group phase 3 trial for untreated pediatric acute myeloid leukemia (AML). Blood. 2007;111:1044-1053.
6. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood. 1996;87:4979-4989.
7. Woods WG, Neudorf S, Gold S, et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood. 2001;97:56-62.
8. Alonzo TA, Kobrinsky NL, Aledo A, Lange BJ, Buxton AB1 Woods WG. Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group. J Pediatr Hematol Oncol. 2002;24:627-635.
9. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14.
10. Garnis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891. J Clin Oncol. 2000;18:1845-1855.
11. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 2005;142(12 pt 1):979-995.
12. Engels EA, Lau J, Barza M. Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol, 1998;16:1179-1187.
13. Dekker A, Bulley S, Beyene J, Dupuis LL, Doyle JJ, Sung L. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol. 2006;24:5207-5215.
14. Lange BJ, Gerbing RB, Feusner J, et al. Mortality in over-weight and underweight children with acute myeloid leukemia. JAMA. 2005;293:203-211.